NON-HODGKIN'S Lymphoma
treatment Ribomustin
(bendamustine) from Janssen-Cilag
is to be authority listed on the
PBS under defined circumstances
effective 01 May.
Lymphoma expert, Associate
Professor Stephen Opat, Consultant
Haematologist from Monash Health
said that he had seen first-hand
the benefits of the drug which he
described as “more effective and
less toxic” than the most commonly
used chemotherapy.
“The majority of patients can
continue with their lives while
undergoing treatment,” he said.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Apr 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Apr 16
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.